Antibiotic Treatment Options for Infectious Colitis
For infectious colitis, the first-line antibiotic treatment depends on the specific pathogen, with metronidazole recommended for mild-to-moderate C. difficile colitis and vancomycin recommended for severe C. difficile colitis. 1, 2
Clostridium difficile-Associated Colitis
Disease Severity Assessment
- Assess disease severity to guide treatment choice 3, 2
- Non-severe CDI: stool frequency <4 times daily, no signs of severe colitis, WBC <15×10^9/L 1, 2
- Severe CDI: fever, rigors, hemodynamic instability, peritonitis, ileus, marked leukocytosis, elevated creatinine/lactate, pseudomembranous colitis 1, 2
Treatment Algorithm
Initial episode and first recurrence:
Second or subsequent recurrences:
- Vancomycin 125 mg orally four times daily for at least 10 days 1, 2
- Consider vancomycin taper/pulse strategy (decreasing daily dose with 125 mg every 3 days or a dose every 3 days for 3 weeks) 1
- Fidaxomicin 200 mg twice daily for 10 days may be useful for patients at high risk for recurrence 1, 3
- Teicoplanin 100 mg twice daily can replace oral vancomycin if available 1, 2
Advanced interventions:
- Fecal microbiota transplantation for multiple recurrences that have failed appropriate antibiotic treatments 1
- Bezlotoxumab (monoclonal antibody) may prevent recurrences, particularly in immunocompromised patients and severe CDI 1
- Colectomy for perforation, systemic inflammation not responding to antibiotics, toxic megacolon, or severe ileus 1, 2
Important Considerations
- Discontinue the inciting antibiotic if possible 1, 2
- Avoid antiperistaltic agents and opiates 1, 2
- Consider discontinuing proton pump inhibitors if not medically necessary 1, 3
- Implement infection control measures: private room, hand hygiene with soap and water, contact precautions 1
Other Bacterial Causes of Infectious Colitis
- For febrile dysenteric diarrhea caused by invasive bacterial enteropathogens (Shigella, Salmonella, Campylobacter): Azithromycin 1000 mg as a single dose 4
- For empiric treatment when specific pathogen is unknown: obtain stool culture before initiating antimicrobial therapy 4, 5
- For suspected Shiga toxin-producing E. coli (STEC): avoid antibiotics as they may increase risk of hemolytic uremic syndrome 4
Inflammatory Bowel Disease-Associated Colitis
- Antibiotics are not first-line therapy for ulcerative colitis 2, 6
- For Crohn's disease with suppurative complications (abscesses, fistulas): ciprofloxacin, metronidazole, or combination of both 6
- Rifaximin has shown promising results for active luminal Crohn's disease 6
Pitfalls and Caveats
- Vancomycin must be given orally for C. difficile colitis; parenteral administration is not effective for this indication 7
- Almost all antibiotics can potentially cause C. difficile colitis, including vancomycin and metronidazole when used parenterally 8
- Relapses occur in 5-50% of treated patients 8
- Monitor renal function in patients >65 years receiving oral vancomycin, as nephrotoxicity can occur 7
- Severe dermatologic reactions including toxic epidermal necrolysis and Stevens-Johnson syndrome have been reported with vancomycin use 7